These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18701807)

  • 1. The potential functional interaction of biglycan and WISP-1 in controlling differentiation and proliferation of osteogenic cells.
    Inkson CA; Ono M; Bi Y; Kuznetsov SA; Fisher LW; Young MF
    Cells Tissues Organs; 2009; 189(1-4):153-7. PubMed ID: 18701807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta1 and WISP-1/CCN-4 can regulate each other's activity to cooperatively control osteoblast function.
    Inkson CA; Ono M; Kuznetsov SA; Fisher LW; Robey PG; Young MF
    J Cell Biochem; 2008 Aug; 104(5):1865-78. PubMed ID: 18404666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix proteoglycans control the fate of bone marrow stromal cells.
    Bi Y; Stuelten CH; Kilts T; Wadhwa S; Iozzo RV; Robey PG; Chen XD; Young MF
    J Biol Chem; 2005 Aug; 280(34):30481-9. PubMed ID: 15964849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WISP-1 binds to decorin and biglycan.
    Desnoyers L; Arnott D; Pennica D
    J Biol Chem; 2001 Dec; 276(50):47599-607. PubMed ID: 11598131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity.
    Ono M; Inkson CA; Kilts TM; Young MF
    J Bone Miner Res; 2011 Jan; 26(1):193-208. PubMed ID: 20684029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt-induced secreted protein-1 is a prohypertrophic and profibrotic growth factor.
    Colston JT; de la Rosa SD; Koehler M; Gonzales K; Mestril R; Freeman GL; Bailey SR; Chandrasekar B
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1839-46. PubMed ID: 17616748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts.
    Bi Y; Nielsen KL; Kilts TM; Yoon A; A Karsdal M; Wimer HF; Greenfield EM; Heegaard AM; Young MF
    Bone; 2006 Jun; 38(6):778-86. PubMed ID: 16364709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of glucocorticoid on the synthesis of biglycan and decorin in human osteoblasts and bone marrow stromal cells.
    Kimoto S; Cheng SL; Zhang SF; Avioli LV
    Endocrinology; 1994 Dec; 135(6):2423-31. PubMed ID: 7988427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair.
    French DM; Kaul RJ; D'Souza AL; Crowley CW; Bao M; Frantz GD; Filvaroff EH; Desnoyers L
    Am J Pathol; 2004 Sep; 165(3):855-67. PubMed ID: 15331410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of adhesion and differentiation markers of osteogenic marrow stromal cells.
    Marom R; Shur I; Solomon R; Benayahu D
    J Cell Physiol; 2005 Jan; 202(1):41-8. PubMed ID: 15389528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells.
    Chen XD; Shi S; Xu T; Robey PG; Young MF
    J Bone Miner Res; 2002 Feb; 17(2):331-40. PubMed ID: 11811564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biglycan modulates osteoblast differentiation and matrix mineralization.
    Parisuthiman D; Mochida Y; Duarte WR; Yamauchi M
    J Bone Miner Res; 2005 Oct; 20(10):1878-86. PubMed ID: 16160746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation.
    Chen XD; Fisher LW; Robey PG; Young MF
    FASEB J; 2004 Jun; 18(9):948-58. PubMed ID: 15173106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biglycan-deficient mice have delayed osteogenesis after marrow ablation.
    Chen XD; Allen MR; Bloomfield S; Xu T; Young M
    Calcif Tissue Int; 2003 May; 72(5):577-82. PubMed ID: 12724831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WISP-1 drives bone formation at the expense of fat formation in human perivascular stem cells.
    Meyers CA; Xu J; Asatrian G; Ding C; Shen J; Broderick K; Ting K; Soo C; Peault B; James AW
    Sci Rep; 2018 Oct; 8(1):15618. PubMed ID: 30353078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix protein biglycan induces osteoblast differentiation through extracellular signal-regulated kinase and Smad pathways.
    Wang X; Harimoto K; Xie S; Cheng H; Liu J; Wang Z
    Biol Pharm Bull; 2010; 33(11):1891-7. PubMed ID: 21048317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1.
    Shao H; Cai L; Grichnik JM; Livingstone AS; Velazquez OC; Liu ZJ
    Oncogene; 2011 Oct; 30(42):4316-26. PubMed ID: 21516124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biglycan is a new extracellular component of the Chordin-BMP4 signaling pathway.
    Moreno M; Muñoz R; Aroca F; Labarca M; Brandan E; Larraín J
    EMBO J; 2005 Apr; 24(7):1397-405. PubMed ID: 15775969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of Wnt-induced secreted protein-1 (WISP-1/CCN4) in esophageal squamous cell carcinoma.
    Nagai Y; Watanabe M; Ishikawa S; Karashima R; Kurashige J; Iwagami S; Iwatsuki M; Baba Y; Imamura Y; Hayashi N; Baba H
    Anticancer Res; 2011 Mar; 31(3):991-7. PubMed ID: 21498727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer.
    Chen PP; Li WJ; Wang Y; Zhao S; Li DY; Feng LY; Shi XL; Koeffler HP; Tong XJ; Xie D
    PLoS One; 2007 Jun; 2(6):e534. PubMed ID: 17579708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.